DG Preventive
Preventive genetic studies to determine a person's genetic predisposition to suffer from different hereditary diseases.
Home page " DG Preventive
Information brochures
Documentation
- EDTA blood (1x 5 ml)
- Saliva (specific Isohelix kit)
- Buccal exudate (2x sterile isopes)
- gDNA (>30 ng/μl in >100 μl TE buffer)
Remember to label each sample with the patient's first and last name or with the identifier used on the request form.
DG Preventive Cardio
125 genes
ABCC9, ABCG5, ABCG8, ACTA2, ACTC1, ACTN2, ACVRL1, AKAP9, ALPK3, ANK2, APOB, BAG3, CACNA1C, CACNB2, CALM1, CALM2, CALM3, CASQ2, CAV3, COL3A1, CRYAB, CSRP3, DES, DMD, DPP6, DSC2, DSG2, DSP, DTNA, EFEMP2, ELN, EMD, ENG, F2, F5, F9, FBN1, FBN2, FHL1, FKTN, FLNA, FLNC, GAA, GDF2, GJA5, GLA, GPD1L, HCN4, HFE, JPH2, JUP, KCNA5, KCND3, KCNE1, KCNE2, KCNE3, KCNH2, KCNJ2, KCNJ5, KCNQ1, LAMA4, LAMP2, LDB3, LDLR, LDLRAP1, LIPA, LMNA, LOX, MFAP5, MIB1, MYBPC3, MYH11, MYH6, MYH7, MYL2, MYL3, MYLK, MYLK2, MYOZ2, MYPN, NEXN, NKX2-5, NOTCH1, NPPA, PCSK9, PKP2, PLN, PPCS, PRDM16, PRKAG2, PRKG1, PSEN1, RAF1, RBM20, RYR2, SCN1B, SCN2B, SCN3B, SCN4B, SCN5A, SGCD, SKI, SLC2A10, SLC4A3, SMAD2, SMAD3, SMAD4, SNTA1, TBX5, TCAP, TECRL, TGFB2, TGFB3, TGFBR1, TGFBR2, TMEM43, TNNC1, TNNI3, TNNT2, TPM1, TRDN, TRPM4, TTN, TTR, VCL
DG Preventive Cardio is a preventive genetic test that analyzes 125 genes associated with 34 inherited cardiovascular diseases.
All the genes included in this test have been selected on the basis of clinical and scientific criteria based on the recommendations of the ACMG(American College of Medical Genetics and Genomics) and other scientific societies, such as the American Heart Association.
Information
-
Analysis: SNVs, Indels and CNVs -
Results: Pathogenic and Probably Pathogenic variants are reported. -
Medium coverage: >100X -
Delivery time: 25 working days
DG Preventive Cancer
86 genes
AIP, AKT1, APC, ATM, AXIN2, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDC73, CDH1, CDK4, CDKN1B, CDKN2A, CHEK2, DDB2, DICER1, EPCAM, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, FH, FLCN, GREM1, HNF1A, HNF1B, HOXB13, KIT, MAX, MEN1, MET, MITF, MLH1, MLH3, MSH2, MSH3, MSH6, MSR1, MUTYH, NBN, NF1, NF2, NKX2-1, NTHL1, PALB2, PDGFRA, PIK3CA, PMS2, POLD1, POLE, POLH, PRKAR1A, PTCH1, PTEN, RAD51, RAD51C, RAD51D, RB1, RET, RNASEL, RNF43, RPS20, SDHA, SDHAF2, SDHB, SDHC, SDHD, SEC23B, SMAD4, SMARCA4, SMARCB1, STK11, TGFBR2, TMEM127, TP53, TSC1, TSC2, USF3, VHL, XPA, XPC, WT1
DG Preventive Cancer is a preventive genetic test that studies 86 genes related to the susceptibility to develop different types of hereditary cancer.
All the genes included in this test have been selected on the basis of clinical and scientific criteria based on the recommendations of the ACMG(American College of Medical Genetics and Genomics) and other scientific societies, such as the Spanish Society of Medical Oncology.
Information
-
Analysis: SNVs, Indels and CNVs -
Results: Pathogenic and Probably Pathogenic variants are reported. -
Medium coverage: >100X -
Delivery time: 25 working days
DG Preventive Essential
81 genes
DG Preventive Essential is a test that analyzes the 81 actionable genes whose study is recommended by the ACMG in the update published in July 2023 (ACMG SF V3.2) and which are related to 37 high-incidence diseases, most of them cardiovascular diseases and cancer.
Information
-
Analysis: SNVs, Indels and CNVs -
Results: Pathogenic and Probably Pathogenic variants are reported. -
Medium coverage: >100X -
Delivery time: 25 working days
DG Preventive Premium
340 genes
ABCA3, ABCA4, ABCC8, ABCC9, ABCD1, ABCG5, ABCG8, ACADM, ACADVL, ACAT1, ACTA2, ACTC1, ACTN2, ACVRL1, ADA, AFF2, AGA, AGXT, AHI1, AIP, AIRE, AKAP9, AKT1, ALDOB, ALPK3, ALPL, ANK2, ANO10, APC, APOB, AR, ARSA, ARX, ASL, ASPA, ASS1, ATM, ATP7B, AXIN2, BAG3, BAP1, BARD1, BBS1, BBS2, BCKDHB, BLM, BMPR1A, BRCA1, BRCA2, BRIP1, BTD, CACNA1C, CACNA1S, CACNB2, CALM1, CALM2, CALM3, CAPN3, CASQ2, CAV3, CBS, CC2D2A, CCDC88C, CDC73, CDH1, CDK4, CDKN1B, CDKN2A, CEP290, CFTR, CHEK2, CHRNE, CLCN1, CLRN1, CNGB3, COL3A1, COL4A3, COL4A4, COL4A5, COL7A1, CPT2, CRB1, CRYAB, CSRP3, CYP11A1, CYP21A2, CYP27A1, CYP27B1, DCLRE1C, DDB2, DES, DHCR7, DHDDS, DICER1, DLD, DMD, DPP6, DSC2, DSG2, DSP, DTNA, DYNC2H1, EFEMP2, ELN, ELP1, EMD, ENG, EPCAM, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, EVC2, F2, F5, F8, F9, FAH, FANCA, FANCC, FBN1, FBN2, FH, FHL1, FKRP, FKTN, FLCN, FLNA, FLNC, FMO3, G6PC, G6PD, GAA, GALNS, GALT, GBA, GBE1, GDF2, GJA5, GJB2, GLA, GNPTAB, GNRHR, GPD1L, GREM1, GRIP1, HBA1, HBA2, HBB, HCN4, HEXA, HFE, HGSNAT, HNF1A, HNF1B, HOXB13, HPS1, HPS3, IDUA, IL2RG, JPH2, JUP, KCNA5, KCND3, KCNE1, KCNE2, KCNE3, KCNH2, KCNJ2, KCNJ5, KCNQ1, KIT, L1CAM, LAMA4, LAMP2, LDB3, LDLR, LDLRAP1, LIPA, LMNA, LOX, LRP2, MAX, MCCC2, MCOLN1, MCPH1, MECP2, MEFV, MEN1, MET, MFAP5, MIB1, MID1, MITF, MLC1, MLH1, MLH3, MMACHC, MMUT, MSH2, MSH3, MSH6, MUTYH, MVK, MYBPC3, MYH11, MYH6, MYH7, MYL2, MYL3, MYLK, MYLK2, MYO7A, MYOZ2, MYPN, NAGA, NAGLU, NBN, NEB, NEXN, NF1, NF2, NKX2-1, NKX2-5, NOTCH1, NPHS1, NPPA, NR0B1, NTHL1, OCA2, OTC, OTOF, PAH, PALB2, PCDH15, PCSK9, PDGFRA, PIK3CA, PKHD1, PKP2, PLN, PLP1, PMM2, PMS2, POLD1, POLE, POLG, POLH, PPCS, PRDM16, PRF1, PRKAG2, PRKAR1A, PRKG1, PSEN1, PTCH1, PTEN, RAD51, RAD51C, RAD51D, RAF1, RARS2, RB1, RBM20, RET, RNASEH2B,RNASEL, RNF43, RPE65, RPGR, RPS20, RS1, RYR1, RYR2, SAG, SCN1B, SCN2B, SCN3B, SCN4B, SCN5A, SCO2, SDHA, SDHAF2, SDHB, SDHC, SDHD, SEC23B, SERPINA1, SGCD, SKI, SLC19A3, SLC26A2, SLC26A4, SLC2A10, SLC37A4, SLC4A3, SLC6A8, SMAD2, SMAD3, SMAD4, SMARCA4, SMARCB1, SMPD1, SNTA1, SPG7, STK11, TBX5, TCAP, TECRL, TF, TGFB2, TGFB3, TGFBR1, TGFBR2, TMEM127, TMEM216, TMEM43, TMPRSS3, TNNC1, TNNI3, TNNT2, TNXB, TP53, TPM1, TRDN, TRPM4, TSC1, TSC2, TSHR, TTN, TTR, TYR, USF3, USH2A, VCL, VHL, WT1, XPA, XPC
DG Preventive Premium is a preventive genetic test that analyzes 340 genes associated with the risk of developing different hereditary diseases, including cardiovascular diseases and cancer, as well as knowing if you are a carrier of an autosomal recessive disease and its risk of transmission to offspring.
The design of the DG Preventive Premium test has followed the recommendations of the ACMG, including the 81 indicated actionable genes, and other scientific societies, such as the Spanish Society of Medical Oncology (SEOM), the American Heart Association (AHA), the American College of Obstetricians and Gynecologists (ACOG) and the Spanish Fertility Society (SEF).
Information
-
Analysis: SNVs, Indels and CNVs -
Results: Pathogenic and Probably Pathogenic variants are reported. -
Medium coverage: >100X -
Delivery time: 25 working days